ResearcherHumanitas UniversityActive in the last 2 years
Federica Marchesi
Matched on ORCID iD 0000-0002-7212-5721; OpenAlex author ID A5015761646, A5137151786. Sources: OpenAlex.
Their work
- Papers
- 13 (first author 0, last author 5)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 46
2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: 2 papers · 2017: none · 2018: none · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 2 papers · 2025: none · 2026: 3 papers
Papers 13
- AISP position statement: Standardising biological sample collection and handling for advanced diagnostics and multi-omic analyses in pancreatic cancer. Co-author DOI 10.1016/j.dld.2026.08.021↗
- Metabolomic profiling of pancreatic juice: a potential prognostic tool for pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.suronc.2026.102456↗
- Multinucleated Giant Cells in Human Pancreatic Cancer Are a Distinct Macrophage Population Undergoing a DNA Damage Response and Associated with an Aggressive T… Last author DOI 10.1158/2326-6066.cir-25-1602↗
- Integrating metabolic profiling of pancreatic juice with transcriptomic analysis of pancreatic cancer tissue identifies distinct clinical subgroups. Last author DOI 10.3389/fonc.2024.1405612↗
- Multiplexed Imaging Mass Cytometry Analysis in Preclinical Models of Pancreatic Cancer. Co-author DOI 10.3390/ijms25031389↗
- The Impact of Molecular Subtyping on Pathological Staging of Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000005050↗
- Oncogenic KRAS-Induced Protein Signature in the Tumor Secretome Identifies Laminin-C2 and Pentraxin-3 as Useful Biomarkers for the Early Diagnosis of Pancreati… Co-author DOI 10.3390/cancers14112653↗
- The Immune Landscape in a Long-Term Survival Pancreatic Adenocarcinoma Patient Highly Responsive to a Multidisciplinary Approach With Chemo-Radio Treatments. Co-author DOI 10.1097/mpa.0000000000001907↗
- Metabolome of Pancreatic Juice Delineates Distinct Clinical Profiles of Pancreatic Cancer and Reveals a Link between Glucose Metabolism and PD-1+ Cells. Last author DOI 10.1158/2326-6066.cir-19-0403↗
- Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma. Co-author DOI 10.3791/61687↗
- Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma. Last author DOI 10.1080/2162402x.2015.1085147↗
- Dual prognostic significance of tumour-associated macrophages in human pancreatic adenocarcinoma treated or untreated with chemotherapy. Last author DOI 10.1136/gutjnl-2015-309193↗
- Molecular mechanisms of pancreatic cancer dissemination: the role of the chemokine system. Co-author DOI 10.2174/13816128112092432↗
Closest collaborators
The 25 strongest of 46 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Alessandro Zerbi · 10 shared papers, 2016–2026 · strength 1.36
- Paper Metabolomic profiling of pancreatic juice: a potential prognostic tool for pancreatic ductal adenocarcinoma. DOI 10.1016/j.suronc.2026.102456↗
- Paper Multinucleated Giant Cells in Human Pancreatic Cancer Are a Distinct Macrophage Population Undergoing a DNA Damage Resp… DOI 10.1158/2326-6066.cir-25-1602↗
- Paper Integrating metabolic profiling of pancreatic juice with transcriptomic analysis of pancreatic cancer tissue identifies… DOI 10.3389/fonc.2024.1405612↗
- Marialuisa Barbagallo · 7 shared papers, 2020–2026 · strength 1.13
- Paper Metabolomic profiling of pancreatic juice: a potential prognostic tool for pancreatic ductal adenocarcinoma. DOI 10.1016/j.suronc.2026.102456↗
- Paper Multinucleated Giant Cells in Human Pancreatic Cancer Are a Distinct Macrophage Population Undergoing a DNA Damage Resp… DOI 10.1158/2326-6066.cir-25-1602↗
- Paper Integrating metabolic profiling of pancreatic juice with transcriptomic analysis of pancreatic cancer tissue identifies… DOI 10.3389/fonc.2024.1405612↗
- Giovanni Luigi Capretti · 8 shared papers, 2016–2026 · strength 1.08
- Paper Metabolomic profiling of pancreatic juice: a potential prognostic tool for pancreatic ductal adenocarcinoma. DOI 10.1016/j.suronc.2026.102456↗
- Paper Multinucleated Giant Cells in Human Pancreatic Cancer Are a Distinct Macrophage Population Undergoing a DNA Damage Resp… DOI 10.1158/2326-6066.cir-25-1602↗
- Paper Integrating metabolic profiling of pancreatic juice with transcriptomic analysis of pancreatic cancer tissue identifies… DOI 10.3389/fonc.2024.1405612↗
- Gennaro Nappo · 4 shared papers, 2020–2026 · strength 0.65
- Paper Metabolomic profiling of pancreatic juice: a potential prognostic tool for pancreatic ductal adenocarcinoma. DOI 10.1016/j.suronc.2026.102456↗
- Paper Integrating metabolic profiling of pancreatic juice with transcriptomic analysis of pancreatic cancer tissue identifies… DOI 10.3389/fonc.2024.1405612↗
- Paper Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma. DOI 10.3791/61687↗
- Paola Cappello · 4 shared papers, 2016–2026 · strength 0.63
- Paper AISP position statement: Standardising biological sample collection and handling for advanced diagnostics and multi-omi… DOI 10.1016/j.dld.2026.08.021↗
- Paper Multiplexed Imaging Mass Cytometry Analysis in Preclinical Models of Pancreatic Cancer. DOI 10.3390/ijms25031389↗
- Paper Metabolome of Pancreatic Juice Delineates Distinct Clinical Profiles of Pancreatic Cancer and Reveals a Link between Gl… DOI 10.1158/2326-6066.cir-19-0403↗
- Nina Cortese · 6 shared papers, 2016–2024 · strength 0.61
- Paper Integrating metabolic profiling of pancreatic juice with transcriptomic analysis of pancreatic cancer tissue identifies… DOI 10.3389/fonc.2024.1405612↗
- Paper The Immune Landscape in a Long-Term Survival Pancreatic Adenocarcinoma Patient Highly Responsive to a Multidisciplinary… DOI 10.1097/mpa.0000000000001907↗
- Paper Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma. DOI 10.3791/61687↗
- Francesca Gavazzi · 5 shared papers, 2016–2026 · strength 0.58
- Paper Metabolomic profiling of pancreatic juice: a potential prognostic tool for pancreatic ductal adenocarcinoma. DOI 10.1016/j.suronc.2026.102456↗
- Paper Oncogenic KRAS-Induced Protein Signature in the Tumor Secretome Identifies Laminin-C2 and Pentraxin-3 as Useful Biomark… DOI 10.3390/cancers14112653↗
- Paper Metabolome of Pancreatic Juice Delineates Distinct Clinical Profiles of Pancreatic Cancer and Reveals a Link between Gl… DOI 10.1158/2326-6066.cir-19-0403↗
- Marco Erreni · 3 shared papers, 2020–2026 · strength 0.50
- Paper Multinucleated Giant Cells in Human Pancreatic Cancer Are a Distinct Macrophage Population Undergoing a DNA Damage Resp… DOI 10.1158/2326-6066.cir-25-1602↗
- Paper Multiplexed Imaging Mass Cytometry Analysis in Preclinical Models of Pancreatic Cancer. DOI 10.3390/ijms25031389↗
- Paper Metabolome of Pancreatic Juice Delineates Distinct Clinical Profiles of Pancreatic Cancer and Reveals a Link between Gl… DOI 10.1158/2326-6066.cir-19-0403↗
- Greta Donisi · 3 shared papers, 2020–2026 · strength 0.42
- Paper Multinucleated Giant Cells in Human Pancreatic Cancer Are a Distinct Macrophage Population Undergoing a DNA Damage Resp… DOI 10.1158/2326-6066.cir-25-1602↗
- Paper Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma. DOI 10.3791/61687↗
- Paper Metabolome of Pancreatic Juice Delineates Distinct Clinical Profiles of Pancreatic Cancer and Reveals a Link between Gl… DOI 10.1158/2326-6066.cir-19-0403↗
- Paola Allavena · 5 shared papers, 2012–2022 · strength 0.34
- Paper Oncogenic KRAS-Induced Protein Signature in the Tumor Secretome Identifies Laminin-C2 and Pentraxin-3 as Useful Biomark… DOI 10.3390/cancers14112653↗
- Paper Metabolome of Pancreatic Juice Delineates Distinct Clinical Profiles of Pancreatic Cancer and Reveals a Link between Gl… DOI 10.1158/2326-6066.cir-19-0403↗
- Paper Dual prognostic significance of tumour-associated macrophages in human pancreatic adenocarcinoma treated or untreated w… DOI 10.1136/gutjnl-2015-309193↗
- Alessandra Pulvirenti · 2 shared papers, 2023–2024 · strength 0.30
- Antonio Pea · 2 shared papers, 2023–2024 · strength 0.30
- Nigel Balfour Jamieson · 2 shared papers, 2023–2024 · strength 0.30
- David Kuang-Fu Chang · 2 shared papers, 2023–2024 · strength 0.30
- Enza Lonardo · 1 shared paper, 2026 · strength 0.30
- Silvia Carrara · 1 shared paper, 2026 · strength 0.30
- Claudio Luchini · 1 shared paper, 2026 · strength 0.30
- Manuel Gentiluomo · 1 shared paper, 2026 · strength 0.30
- Elisa Giovannetti · 1 shared paper, 2026 · strength 0.30
- Salvatore Paiella · 1 shared paper, 2026 · strength 0.30
- Elena Desiato · 1 shared paper, 2026 · strength 0.28
- Marika Viatore · 1 shared paper, 2026 · strength 0.22
- Vincenzo Corbo · 1 shared paper, 2026 · strength 0.22
- Silvia Bozzarelli · 1 shared paper, 2026 · strength 0.22
- Lisa Veghini · 1 shared paper, 2026 · strength 0.22
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.